ProPhase Labs, Inc.ProPhase Labs, Inc.ProPhase Labs, Inc.

ProPhase Labs, Inc.

No trades
See on Supercharts
Market capitalization
‪117.65 M‬USD
−0.96USD
‪−16.78 M‬USD
‪44.38 M‬USD
‪14.07 M‬
Beta (1Y)
−0.23

About ProPhase Labs, Inc.

CEO
Ted William Karkus
Headquarters
Garden City
Employees (FY)
113
Founded
1989
ISIN
US74345W1080
FIGI
BBG000F5PGF2
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PRPH is 6.52 USD — it has increased by 1.87% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ProPhase Labs, Inc. stocks are traded under the ticker PRPH.
ProPhase Labs, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ProPhase Labs, Inc. has a max estimate of 11.00 USD and a min estimate of 11.00 USD.
PRPH earnings for the last quarter are −0.30 USD whereas the estimation was −0.20 USD which accounts for −53.85% surprise. Estimated earnings for the next quarter are −0.26 USD. See more details about ProPhase Labs, Inc. earnings.
ProPhase Labs, Inc. revenue for the last quarter amounts to ‪8.37 M‬ USD despite the estimated figure of ‪13.06 M‬ USD. In the next quarter revenue is expected to reach ‪10.71 M‬ USD.
Yes, you can track ProPhase Labs, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, PRPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ProPhase Labs, Inc. stock right from TradingView charts — choose your broker and connect to your account.
PRPH reached its all-time high on Oct 14, 1997 with the price of 22.58 USD, and its all-time low was 0.31 USD and was reached on Apr 9, 1996.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has 113.00 employees. See our rating of the largest employees — is ProPhase Labs, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ProPhase Labs, Inc. EBITDA is ‪−14.92 M‬ USD, and current EBITDA margin is −33.60%. See more stats in ProPhase Labs, Inc. financial statements.